{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:43:06Z","timestamp":1791027786359,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":2451,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.bbadis.2006.05.003","type":"journal-article","created":{"date-parts":[[2006,5,23]],"date-time":"2006-05-23T20:50:00Z","timestamp":1148417400000},"page":"1122-1127","source":"Crossref","is-referenced-by-count":27,"title":["Gene Therapy for ALS: Progress and prospects"],"prefix":"10.1016","volume":"1762","author":[{"given":"Mimoun","family":"Azzouz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2006.05.003_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jgm.707","article-title":"Viral vectors as tools to model and treat neurodegenerative disorders","volume":"7","author":"Deglon","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hum.2006.17.1","article-title":"Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications","volume":"17","author":"Wong","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbadis.2006.05.003_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrn1104","article-title":"Viral vectors for gene delivery to the nervous system","volume":"4","author":"Davidson","year":"2003","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib4","first-page":"191","article-title":"Lentiviruses as vectors for CNS diseases","volume":"261","author":"Deglon","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib5","first-page":"476","article-title":"Lentiviral vectors for the treatment of neurodegenerative diseases","volume":"3","author":"Martin-Rendon","year":"2001","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.bbadis.2006.05.003_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0076-6879(02)46072-7","article-title":"Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors","volume":"346","author":"Rohll","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/365666a0","article-title":"A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells","volume":"365","author":"Burkrinsky","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.05.003_bib8","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1128\/JVI.70.2.1027-1032.1996","article-title":"Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import","volume":"70","author":"Gallay","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib9","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/10.19.2109","article-title":"Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery","volume":"10","author":"Mazarakis","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2006.05.003_bib10","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1523\/JNEUROSCI.22-23-10302.2002","volume":"22","author":"Azzouz","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/exnr.2000.7409","article-title":"Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF","volume":"164","author":"Bensadoun","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S1525-0016(03)00069-8","article-title":"Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin","volume":"7","author":"Bienemann","year":"2003","journal-title":"Molec. Ther."},{"key":"10.1016\/j.bbadis.2006.05.003_bib13","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1128\/JVI.71.9.6641-6649.1997","article-title":"Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector","volume":"71","author":"Blomer","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib14","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1073\/pnas.93.21.11382","article-title":"Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector","volume":"93","author":"Naldini","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2006.05.003_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2006.05.003_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jgm.845","article-title":"Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors","volume":"8","author":"Balaggan","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib17","doi-asserted-by":"crossref","first-page":"18206","DOI":"10.1073\/pnas.0407976101","article-title":"Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo","volume":"101","author":"Dittgen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2006.05.003_bib18","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jgm.600","article-title":"Lentiviral vectors for treating and modeling human CNS disorders","volume":"6","author":"Azzouz","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0300-9084(02)00036-6","article-title":"Vectors derived from simian immunodeficiency virus (SIV)","volume":"84","author":"Negre","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2006.05.003_bib20","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/sj.gt.3301023","article-title":"Stable gene transfer to the nervous system using a non-primate lentiviral vector","volume":"6","author":"Mitrophanous","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbadis.2006.05.003_bib21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nm0398-354","article-title":"Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors","volume":"4","author":"Poeschla","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib22","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/3953","article-title":"When accessories turn out to be essential","volume":"4","author":"Trono","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JVI.72.1.811-816.1998","article-title":"Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1","volume":"72","author":"Kim","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib24","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib25","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1172\/JCI8390","article-title":"Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect","volume":"104","author":"Wang","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2006.05.003_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/viro.2001.1183","article-title":"A novel lentivirus vector derived from apathogenic simian immunodeficiency virus","volume":"291","author":"Stitz","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.bbadis.2006.05.003_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/10430340050016256","article-title":"Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease","volume":"11","author":"Deglon","year":"2000","journal-title":"Hum. Genet. Ther."},{"key":"10.1016\/j.bbadis.2006.05.003_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/mthe.2002.0681","article-title":"Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes","volume":"6","author":"MacKenzie","year":"2002","journal-title":"Molec. Ther."},{"key":"10.1016\/j.bbadis.2006.05.003_bib29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1006\/mthe.2002.0584","article-title":"Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins","volume":"5","author":"Watson","year":"2002","journal-title":"Molec. Ther."},{"key":"10.1016\/j.bbadis.2006.05.003_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","article-title":"VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model","volume":"429","author":"Azzouz","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.05.003_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/85664","article-title":"Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo","volume":"19","author":"Kobinger","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymthe.2003.09.017","article-title":"Transduction patterns of pseudotyped lentiviral vectors in the nervous system","volume":"9","author":"Wong","year":"2004","journal-title":"Molec. Ther."},{"key":"10.1016\/j.bbadis.2006.05.003_bib33","first-page":"245","article-title":"Opportunities for the use of lentiviral vectors in human Gene Therapy","volume":"261","author":"Galimi","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib34","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1525-0016(03)00074-1","article-title":"Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectors","volume":"7","author":"O'Rourke","year":"2003","journal-title":"Molec. Ther."},{"key":"10.1016\/j.bbadis.2006.05.003_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00109-005-0649-1","article-title":"Therapeutic gene silencing in neurodegenerative disease using interfering RNA","volume":"83","author":"Ralph","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib36","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1073\/pnas.95.5.2603","article-title":"Bcl-xL protects adult septal cholinergic neurons from axotomized cell death","volume":"95","author":"Blomer","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2006.05.003_bib37","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease","volume":"99","author":"Lo Bianco","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2006.05.003_bib38","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"de Almeida","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib39","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cell.2006.01.040","article-title":"A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen","volume":"124","author":"Moffat","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2006.05.003_bib40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archneur.58.3.512","article-title":"How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean\u2013Martin Charcot","volume":"58","author":"Rowland","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0025-6196(12)61175-6","article-title":"Motor neuron disease (amyotrophic lateral sclerosis)","volume":"66","author":"Williams","year":"1991","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbadis.2006.05.003_bib42","first-page":"15","article-title":"Clinical limits of amyotrophic lateral sclerosis","volume":"36","author":"Mulder","year":"1982","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib43","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/364362c0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"364","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.05.003_bib44","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2006.05.003_bib45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00019052-199508000-00008","article-title":"Motor neuron disease caused by mutations in superoxide dismutase 1","volume":"8","author":"Wong","year":"1995","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0092-8674(01)00244-6","article-title":"Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded","volume":"104","author":"Julien","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2006.05.003_bib47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35097565","article-title":"From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS","volume":"2","author":"Cleveland","year":"2001","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis, ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib49","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410390203","article-title":"Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis","volume":"39","author":"Gurney","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1126\/science.288.5464.335","article-title":"Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model","volume":"288","author":"Li","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2006.05.003_bib52","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","article-title":"Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis","volume":"5","author":"Klivenyi","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.05.003_bib54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.10374","article-title":"Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS","volume":"52","author":"Drachman","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nm1021","article-title":"Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice","volume":"10","author":"Kieran","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11910-003-0041-x","article-title":"Recent advances in amyotrophic lateral sclerosis research","volume":"3","author":"Przedborski","year":"2003","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bbadis.2006.05.003_bib57","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/01.WNL.0000142992.81995.F0","article-title":"A clinical trial of creatine in ALS","volume":"63","author":"Shefner","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2006.05.003_bib58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10072-005-0474-x","article-title":"Minocycline in amyotrophic lateral sclerosis: a pilot study","volume":"26","author":"Pontieri","year":"2005","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib59","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1517\/14656566.5.4.735","article-title":"Current pharmacological management of amyotrophic corrected. lateral sclerosis and a role for rational polypharmacy","volume":"5","author":"Weiss","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bbadis.2006.05.003_bib60","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.22-16-06920.2002","article-title":"Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis","volume":"22","author":"Wang","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib61","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2006.05.003_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nn1360","article-title":"Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS","volume":"8","author":"Storkebaum","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib63","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q","article-title":"Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease","volume":"46","author":"Kordower","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0166-2236(00)01899-3","article-title":"Recombinant proteins for neurodegenerative diseases: the delivery issue","volume":"24","author":"Aebischer","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1474-4422(02)00006-6","article-title":"Growth-factor Gene Therapy for neurodegenerative disorders","volume":"1","author":"Tuszynski","year":"2002","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib66","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1046\/j.1471-4159.2000.0741820.x","article-title":"Efficient gene transfer and expression of biologically active glial cell line-derived neurotrophic factor in rat motoneurons transduced wit lentiviral vectors","volume":"74","author":"Cisterni","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2006.05.003_bib67","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1523\/JNEUROSCI.20-15-05587.2000","article-title":"Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus","volume":"20","author":"Hottinger","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib68","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI22922","article-title":"LentiVector-mediated SMN replacement in a mouse model of spinal muscular atrophy","volume":"114","author":"Azzouz","year":"2004","journal-title":"The J. Clin. Investig."},{"key":"10.1016\/j.bbadis.2006.05.003_bib69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1205","article-title":"Silencing of mutant SOD1 using interfering RNA induces long term reversal of ALS in a transgenic mouse model","volume":"11","author":"Ralph","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib70","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1207","article-title":"Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS","volume":"11","author":"Raoul","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib71","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt936","article-title":"Rational siRNA design for RNA interference","volume":"22","author":"Reynolds","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib72","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tibtech.2004.07.008","article-title":"Picking a winner: new mechanistic insights into the design of effective siRNAs","volume":"22","author":"Gong","year":"2004","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ng944","article-title":"Efficient delivery of siRNA for inhibition of gene expression in postnatal mice","volume":"32","author":"Lewis","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2006.05.003_bib74","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-2836(03)00181-5","article-title":"Gene silencing by systemic delivery of synthetic siRNAs in adult mice","volume":"327","author":"Sorensen","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2006.05.003_bib76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(04)00678-7","article-title":"Molecular medicine for the brain: silencing of disease genes with RNA interference","volume":"3","author":"Davidson","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib77","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/nass\/2.1.113","article-title":"Development and application of siRNA expression vector","author":"Miyagishi","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2006.05.003_bib78","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1128\/JVI.77.16.8957-8951.2003","article-title":"Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference","volume":"77","author":"Wiznerowicz","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib79","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nm1076","article-title":"RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia","volume":"10","author":"Xia","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2006.05.003_bib80","doi-asserted-by":"crossref","first-page":"10502","DOI":"10.1523\/JNEUROSCI.3016-05.2005","article-title":"Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia","volume":"25","author":"Gonzalez-Alegre","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib81","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2006.05.003_bib82","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nn1531","article-title":"Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model","volume":"8","author":"Singer","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2006.05.003_bib83","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ana.20453","article-title":"Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis","volume":"57","author":"Miller","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2006.05.003_bib84","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.gt.3302666","article-title":"A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors","volume":"13","author":"Miskin","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbadis.2006.05.003_bib85","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1089\/hum.2005.16.1227","article-title":"Product-enhanced reverse transcriptase assay for replication-competent retrovirus and lentivirus detection","volume":"16","author":"Sastry","year":"2005","journal-title":"Hum. Gene Ther."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443906000834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443906000834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:48:45Z","timestamp":1586911725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443906000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":85,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0925443906000834"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2006.05.003","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}